Compare OSIS & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OSIS | AMRX |
|---|---|---|
| Founded | 1987 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.0B |
| IPO Year | 1997 | 2018 |
| Metric | OSIS | AMRX |
|---|---|---|
| Price | $277.64 | $12.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $280.33 | $14.75 |
| AVG Volume (30 Days) | 195.7K | ★ 1.7M |
| Earning Date | 04-30-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 18.02 | ★ 157.89 |
| EPS | ★ 3.39 | 0.22 |
| Revenue | ★ $1,089,286,000.00 | N/A |
| Revenue This Year | $9.86 | $6.40 |
| Revenue Next Year | $5.53 | $6.54 |
| P/E Ratio | $82.44 | ★ $57.77 |
| Revenue Growth | ★ 13.35 | N/A |
| 52 Week Low | $164.08 | $6.69 |
| 52 Week High | $306.12 | $15.42 |
| Indicator | OSIS | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 50.43 | 27.06 |
| Support Level | $244.64 | $12.50 |
| Resistance Level | $297.80 | $12.85 |
| Average True Range (ATR) | 12.33 | 0.44 |
| MACD | -1.26 | -0.20 |
| Stochastic Oscillator | 39.46 | 0.00 |
OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems, and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. The majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East and Africa, and the Asia Pacific regions.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.